Articles Tagged With: exacerbations
-
Chronic Obstructive Pulmonary Disease Update for Primary Care Providers
The Global Initiative for Chronic Obstructive Lung Disease 2023 report defines chronic obstructive pulmonary disease (COPD) as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) caused by abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that result in persistent, often progressive, airflow obstruction. COPD was the fourth leading cause of death in the United States in 2018 and is estimated to be responsible for 3 million deaths annually around the world, with expected increases to 5.4 million annual deaths from COPD and related conditions by 2060.
-
Management of COPD Exacerbations in the ICU: What’s New?
Chronic obstructive pulmonary disease (COPD) exacerbations continue to negatively affect health status, including disease progression and mortality, making optimization of the critically ill COPD patient imperative.
-
Management of Asthma and Chronic Obstructive Pulmonary Disease Exacerbations
This article discusses emergent management of patients with asthma and chronic obstructive pulmonary disease exacerbations, as well as the epidemiology, etiology, and pathophysiology of each condition
-
Assessing and Treating Exacerbations of Chronic Obstructive Pulmonary Disease
People with chronic obstructive pulmonary disease frequently seek care for acute exacerbations, which are associated with significant morbidity and mortality. Therefore, it is crucial for physicians to understand how to assess and treat these patients appropriately.
-
Chronic Obstructive Pulmonary Disease Exacerbations
Acute exacerbations frequently prompt patients with chronic obstructive pulmonary disease to present to the emergency department, so it is crucial for emergency physicians to understand how to assess and treat these patients effectively.
-
Heart Failure-Exacerbating Medications
In a large, diverse cohort of Medicare patients hospitalized for heart failure exacerbations, almost half were on medications known to exacerbate heart failure; more than one-third were on these agents at discharge.
-
CRP and Reduction of Antibiotic Use in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Point-of-care C-reactive protein testing can safely and effectively reduce antibiotic use in patients with acute exacerbations of chronic obstructive lung disease.
-
Azithromycin for Chronic Persistent Asthma
Azithromycin reduced exacerbations and improved quality of life in patients with chronic persistent asthma.
-
Chronic Obstructive Pulmonary Disease: Update
COPD is a chronic, incurable but very treatable condition. This syndrome is identified by historical clues, clinical signs and symptoms, and physiologic and imaging abnormalities.